
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

EHC is expanding its rehabilitation network with a new 36-bed hospital in West Virginia.

BIRMINGHAM, Ala. and BRIDGEPORT, W.Va.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

EHC expands rehab capacity with new hospitals and bed additions, but rising labor costs and debt levels may keep the stock a Hold for now.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today issued notice for redemption of $400 million of the outstanding principal balance of its 4.500% senior notes due 2028 (the "2028 Notes").

BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of $500 million in aggregate principal amount of 5.875% senior notes due 2034 (the "Notes") at a price of 100% of the principal amount thereof.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of $500 million in aggregate principal amount of senior notes maturing in 2034 (the "Notes"), subject to market and other conditions.

Encompass Health Corporation (EHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

EHC plans a new 50-bed inpatient rehab hospital in Post Falls, expanding its footprint in an underserved market with an expected 2028 opening.

BIRMINGHAM, Ala., and POST FALLS, Idaho, May 11, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 50–bed inpatient rehabilitation hospital in Post Falls, Idaho.

HASLET, Texas--(BUSINESS WIRE)--Davidson Bogel Real Estate (DB2RE) is pleased to announce the sale of approximately 7 acres of land located at the southwest corner of Haslet Parkway and Harmon Road in Haslet, Texas. Collins Meier, Ryan Turner, David Davidson, Jr., and Edward Bogel represented the seller in the transaction. The buyer, Encompass Health, partnered closely with the land owner and master developer, Terra Manna, to bring the project to fruition. JLL represented the buyer in the trans.

BIRMINGHAM, Ala., May 7, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on July 15, 2026, to holders of record on July 1, 2026.

EHC posts Q1 EPS beat as revenues rise 9%, driven by higher patient revenue and volumes, though rising costs and expenses temper gains.

BIRMINGHAM, Ala. and GLEN MILLS, Pa.

Encompass Health Corporation (EHC) Q1 2026 Earnings Call Transcript

Although the revenue and EPS for Encompass Health (EHC) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Encompass Health (EHC) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.37 per share a year ago.

Increases full-year guidance BIRMINGHAM, Ala., April 30, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the first quarter ended March 31, 2026.

The mean of analysts' price targets for Encompass Health (EHC) points to a 38.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Ecolab posts in line first-quarter 2026 earnings as revenue beats expectations and Digital sales surge, while gross margin tightens and guidance is revised.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

HSIC heads into Q1 earnings results with steady estimates, a 5.1% revenue growth outlook and strength across distribution, specialty products and tech.

CI approaches Q1 results with strong pharmacy growth but a steep premium drop, as estimates point to mixed year-over-year performance.

Ensign, Encompass Health, Tenet Healthcare and CVS Health look primed for Q1 2026 earnings beats as occupancy, revenue gains and rate hikes help offset rising costs.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Encompass Health (EHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BIRMINGHAM, Ala., April 23, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the BofA Securities 2026 Health Care Conference, which will be held May 12-14, 2026.

Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BIRMINGHAM, Ala. and COOKEVILLE, Tenn.

Asset Management One Co. Ltd. raised its position in shares of Encompass Health Corporation (NYSE: EHC) by 128.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 129,205 shares of the company's stock after purchasing an additional 72,703 shares during

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The average of price targets set by Wall Street analysts indicates a potential upside of 31.7% in Encompass Health (EHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

BIRMINGHAM, Ala., April 8, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) will hold its annual meeting of stockholders at 11 a.m.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

BIRMINGHAM, Ala., April 7, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its first quarter ended March 31, 2026, after the market closes on Thursday, April 30, 2026.

Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Encompass Health Corporation is positioned as the largest U.S. inpatient rehabilitation hospital operator, benefiting from a proposed CMS FY 2027 payment rate increase. The CMS proposal boosts Medicare payments by 2.4%, supporting EHC's revenue outlook, but introduces stricter operational requirements and future payment calculation uncertainties. EHC's expansion strategy leverages strong local presence, efficient staffing, and robust hospital relationships, with planned bed additions of 500–600 per year and resilient discharge growth.

Allspring Global Investments Holdings LLC lifted its position in shares of Encompass Health Corporation (NYSE: EHC) by 690.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 344,093 shares of the company's stock after buying an additional 300,546 shares during the period.

NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

SG Americas Securities LLC lifted its holdings in Encompass Health Corporation (NYSE: EHC) by 1,070.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 88,054 shares of the company's stock after buying an additional 80,534 shares during the quarter. SG Americas Securities LLC

NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Shares of Encompass Health Corporation (NYSE: EHC - Get Free Report) have earned a consensus recommendation of "Buy" from the ten research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Congress Asset Management Co. cut its holdings in shares of Encompass Health Corporation (NYSE: EHC) by 11.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 548,170 shares of the company's stock after selling 71,221 shares during the

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

EHC unveils a 40-bed inpatient rehabilitation hospital in Bear, DE, adding advanced therapy services and expanding its in-state footprint.

NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

BIRMINGHAM, Ala., and BEAR, Del.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Aquatic Capital Management LLC boosted its holdings in Encompass Health Corporation (NYSE: EHC) by 725.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 32,294 shares of the company's stock after acquiring an additional 28,382 shares during the period. Aquatic Capital Management LLC's holdings
